Loading clinical trials...
Loading clinical trials...
The Effect of Palm Tocotrienol Rich Fraction on Alcoholic Fatty Liver Disease (AFLD): A Phase II Clinical Trial
Conditions
Interventions
Palm Tocotrienol Rich Fraction (TRF)
Refined, bleached, and deodorised (RBD) palm olein
Locations
1
Malaysia
Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak
Cheras, Kuala Lumpur, Malaysia
Start Date
March 2, 2026
Primary Completion Date
September 10, 2026
Completion Date
December 15, 2026
Last Updated
March 12, 2026
NCT07265544
NCT07403604
NCT07237750
NCT06819917
NCT07221227
NCT06218589
Lead Sponsor
Universiti Kebangsaan Malaysia Medical Centre
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions